Pacer Advisors Inc. Sells 4,120 Shares of Globe Life Inc. $GL

Pacer Advisors Inc. decreased its holdings in shares of Globe Life Inc. (NYSE:GL) by 50.9% during the first quarter, according to its most recent filing with the SEC. The firm owned 3,977 shares of the company’s stock after selling 4,120 shares during the period. Pacer Advisors Inc.’s holdings in Globe Life were worth $553,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. CYBER HORNET ETFs LLC bought a new position in shares of Globe Life during the second quarter valued at approximately $28,000. Hilton Head Capital Partners LLC purchased a new stake in Globe Life during the fourth quarter worth $30,000. MUFG Securities EMEA plc purchased a new stake in Globe Life during the second quarter worth $31,000. Torren Management LLC bought a new stake in Globe Life during the 4th quarter valued at $37,000. Finally, AdvisorNet Financial Inc increased its holdings in shares of Globe Life by 41.1% in the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares during the period. Institutional investors own 81.61% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. TD Cowen upped their price objective on Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. JPMorgan Chase & Co. boosted their target price on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. Truist Financial increased their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. Wells Fargo & Company raised their price target on shares of Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. Finally, Morgan Stanley lifted their price objective on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $191.67.

Globe Life Trading Down 0.4%

NYSE:GL opened at $183.08 on Tuesday. The company has a market capitalization of $14.07 billion, a P/E ratio of 12.16 and a beta of 0.48. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55. The firm has a fifty day simple moving average of $175.06 and a 200-day simple moving average of $156.22.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The firm had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the business earned $3.05 EPS. The business’s revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities research analysts anticipate that Globe Life Inc. will post 15.7 earnings per share for the current year.

Globe Life Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be paid a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Monday, October 5th. Globe Life’s dividend payout ratio (DPR) is presently 8.76%.

Globe Life announced that its Board of Directors has authorized a stock repurchase program on Monday, August 10th that authorizes the company to buyback $2.50 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 17.7% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its shares are undervalued.

Insider Activity

In related news, Director Cheryl Alston sold 8,258 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total value of $1,480,163.92. Following the sale, the director owned 16,621 shares in the company, valued at $2,979,148.04. This represents a 33.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Thomas Peter Kalmbach sold 21,000 shares of the stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $180.06, for a total transaction of $3,781,260.00. Following the completion of the transaction, the chief financial officer owned 50,568 shares in the company, valued at approximately $9,105,274.08. This trade represents a 29.34% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 191,747 shares of company stock valued at $33,480,408. 2.11% of the stock is owned by insiders.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.